Mark Cuban’s Cost Plus Drugs, Humana In Deal To Take On Employer Drug Costs
InnovationHealthcareMark Cuban’s Cost Plus Drugs, Humana In Deal To Take On Employer Drug CostsByBruce Japsen,Senior Contributor.Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy.Follow AuthorApr 27, 2026, 08:00am EDT--:-- / --:--This voice experience is generated by AI. Learn more.This voice experience is generated by AI. Learn more.Humana's CenterWell Pharmacy announced a partnership with Mark Cuban Cost Plus Drug Company to develop "new, end-to-end employer prescription solutions," the companies announced Monday, April 27, 2026. In this photo, Mark Cuban (center) and Jim Rechtin, CEO of Humana (right), talk with Forbes Senior Healthcare Contributor Bruce Japsen about improving the patient experience at the pharmacy at the Forbes Healthcare Summit on December 4, 2025 at NYU Lagone Health in Manhattan.Jamel ToppinMark Cuban’s Cost Plus Drug Company and Humana’s CenterWell Pharmacy Monday confirmed they have formed a partnership “to develop new end-to-end employer prescription solutions.”Humana, which is best known as a provider of Medicare Advantage health insurance for millions of older adults, also operates the fast-growing CenterWell health services business that includes pharmacy, specialty pharmacy and related distribution. CenterWell contributed more than $22 billion in revenue to Humana’s total sales last year of $129.6 billion, according to the insurer’s most recent financial report.Talk of such a partnership first became public last December at the annual Forbes Healthcare Summit in New York but specifics weren’t revealed at that time. On Monday, the companies said the collaboration has come together and is “focused on discounted prescription and delivery services.” Financial terms weren’t disclosed.As part of the collaboration, CenterWell Pharmacy, which employs more than 500 pharmacists who provide around-the-clock patient support, will be a pharmacy partner of Co...المصدر: Forbes Business | Source: Forbes Business
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة Forbes Business. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by Forbes Business. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.

